Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q2 2014 · 10-Q
Revenue$120.03M$120.03M+4.7% vs Q2 2013 Net Income$3.45M$3.45M−61.3% vs Q2 2013 EPS Diluted$0.13$0.13−61.8% vs Q2 2013 Gross Profit$13,734,000−25.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flowderived-$245,000N/M Free Cash Flowderived-$3,581,000N/M Margins · derivedGross margin11.4%−4.7 pt vs Q2 2013
Operating margin2.6%−7.0 pt vs Q2 2013
Net margin2.9%−4.9 pt vs Q2 2013
ended Nov 24, 2013 · filed Jan 3, 2014 · 40 d after period end